2021
DOI: 10.1186/s13089-021-00223-9
|View full text |Cite
|
Sign up to set email alerts
|

One-month outcomes of patients with SARS-CoV-2 infection and their relationships with lung ultrasound signs

Abstract: Background The role of lung ultrasound (LUS) in evaluating the mid- and long-term prognoses of patients with COVID-19 pneumonia is not yet known. The objectives of this study were to evaluate associations between LUS signs at the time of screening and clinical outcomes 1 month after LUS and to assess LUS signs at the time of presentation with known risk factors for COVID-19 pneumonia. Methods This was a retrospective study of data prospectively col… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
10
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 12 publications
(13 citation statements)
references
References 37 publications
(37 reference statements)
3
10
0
Order By: Relevance
“…In addition, some studies have confirmed the relationship between the persistence of subpleural consolidations and the sensation of dyspnea [ 30 ].…”
Section: Discussionmentioning
confidence: 99%
“…In addition, some studies have confirmed the relationship between the persistence of subpleural consolidations and the sensation of dyspnea [ 30 ].…”
Section: Discussionmentioning
confidence: 99%
“…With the participants in a sitting position, LUS signs were captured in six areas of each hemithorax as follows [ 25 ]: two anterior, two lateral, and two posterior. In the evaluation of the LUS pathological signs, we sought to identify B-lines >2, coalescent B-lines, and subpleural consolidations [ 8 ]. To obtain the aeration score, points were assigned to each of the six areas as follows: B-lines >2, 1 point; coalescent B-lines, 2 points; and consolidations, 3 points.…”
Section: Methodsmentioning
confidence: 99%
“…In this scenario, lung ultrasound (LUS) in the evaluation of patients with COVID-19 has been increasingly used and should be encouraged because it is a practical, low-cost, and radiation-free method, in addition to requiring equipment that is easy to clean [ 5 7 ]. With the increase in the number of studies, LUS has been shown to be a useful tool to monitor lung disease progression in patients with COVID-19, especially considering that SARS-CoV-2 preferentially affects peripheral areas of the lungs where visualization of LUS signs is quite satisfactory [ 8 , 9 ]. In addition, compared to CT, LUS appears to have an excellent discrimination capacity for the identification of pulmonary sequelae in post-COVID-19 follow-ups [ 7 ].…”
Section: Introductionmentioning
confidence: 99%
“…Our unadjusted overall mortality rate of 29% for patients who had been imaged with ultrasound suggests a modest effect of selection bias, as this rate is high but comparable to that of unselected patients in similar-sized U.S. hospitals during the initial wave of the pandemic 37 and similar to other COVID-19 ultrasound outcome studies of older patients. [12][13][14] Concomitant cardiogenic pulmonary edema was not excluded and virus-induced heart failure exacerbation may have been a significant and prevalent comorbidity, 38 which was nonetheless considered attributable to the COVID-19 infection. As a single-center study, our findings represent the prevalence and virulence of cases encountered by a hospital in the downtown San Diego region which has a high proportion of admissions from the surrounding Hispanic community and an underserved homeless population and occurred before widespread vaccination, the appearance of the delta variant, and the development of any standardized outpatient treatments.…”
Section: Discussionmentioning
confidence: 99%